Michael Scolaro

Michael Scolaro

Oct 11, 2017

Group 6 Copy 50
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

    One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

    Giving Children a Better Life: Understanding Developmental Coordination Disorder

    When I was young, I had developmental coordination disorder (DCD). I just didn’t know what it was. Children...

    Backer Badge Funded